Christopher Morgan is a retired partner of international law firm Skadden, Arps, Slate, Meagher & Flom LLP. He was part of the Capital Markets group and led the Toronto office for 30 years. He is a member of the Board of Directors of Alpha Cancer Technologies Inc., a private clinical stage biotechnology company with platform technologies in Immunotherapy and Immuno-Oncology, and Belmont House, a charitable non-profit home for seniors offering long-term care and retirement living. Mr. Morgan holds a Bachelor of Applied Science, J.D. and M.B.A. from the University of Toronto.